Free Trial

Digital Health Acquisition (DHAC) Competitors

Digital Health Acquisition logo
$0.87 +0.04 (+4.82%)
As of 08/21/2025

DHAC vs. BRTX, BGLC, MGRX, SSY, ACON, ATIP, OTRK, NIVF, BACK, and BTTX

Should you be buying Digital Health Acquisition stock or one of its competitors? The main competitors of Digital Health Acquisition include Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Aclarion (ACON), ATI Physical Therapy (ATIP), Ontrak (OTRK), NewGenIvf Group (NIVF), IMAC (BACK), and Better Therapeutics (BTTX). These companies are all part of the "healthcare" industry.

Digital Health Acquisition vs. Its Competitors

Digital Health Acquisition (NASDAQ:DHAC) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, Biorestorative Therapies had 4 more articles in the media than Digital Health Acquisition. MarketBeat recorded 5 mentions for Biorestorative Therapies and 1 mentions for Digital Health Acquisition. Biorestorative Therapies' average media sentiment score of 0.15 beat Digital Health Acquisition's score of 0.00 indicating that Biorestorative Therapies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Digital Health Acquisition
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Biorestorative Therapies
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Digital Health Acquisition has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500. Comparatively, Biorestorative Therapies has a beta of 76.7, indicating that its stock price is 7,570% more volatile than the S&P 500.

Digital Health Acquisition has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -1,772.40%. Digital Health Acquisition's return on equity of 0.00% beat Biorestorative Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
Biorestorative Therapies -1,772.40%-137.00%-88.31%

Digital Health Acquisition has higher earnings, but lower revenue than Biorestorative Therapies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
Biorestorative Therapies$605.20K20.17-$8.98M-$1.27-1.20

1.0% of Digital Health Acquisition shares are held by institutional investors. Comparatively, 69.4% of Biorestorative Therapies shares are held by institutional investors. 6.6% of Digital Health Acquisition shares are held by insiders. Comparatively, 30.8% of Biorestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Biorestorative Therapies beats Digital Health Acquisition on 6 of the 9 factors compared between the two stocks.

Get Digital Health Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAC vs. The Competition

MetricDigital Health AcquisitionHolding Offices IndustryServices SectorNASDAQ Exchange
Market Cap$3.14M$223.07M$1.67B$9.73B
Dividend YieldN/A3.17%N/A4.09%
P/E RatioN/A0.175.4225.96
Price / SalesN/A504.1615.46122.97
Price / CashN/A123.70274.0658.38
Price / BookN/A8.103.436.39
Net IncomeN/A-$11.59M-$16.75M$265.56M
7 Day Performance-1.72%4.43%2.55%1.98%
1 Month Performance-36.50%3.18%-6.83%1.33%
1 Year Performance-50.85%166.71%185.79%21.15%

Digital Health Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAC
Digital Health Acquisition
N/A$0.87
+4.8%
N/A-55.7%$3.14MN/A0.002,021News Coverage
Gap Up
BRTX
Biorestorative Therapies
2.539 of 5 stars
$1.50
flat
N/A-10.6%$11.97M$400K-1.187
BGLC
BioNexus Gene Lab
0.03 of 5 stars
$5.36
-3.8%
N/A+31.9%$10.01M$9.51M0.0030Negative News
Earnings Report
MGRX
Mangoceuticals
0.4471 of 5 stars
$1.58
-7.1%
N/A-97.4%$8.79M$620K-0.343News Coverage
Short Interest ↑
SSY
SunLink Health Systems
2.2141 of 5 stars
$1.12
+16.1%
N/A+37.3%$7.85M$31.09M4.651,376Gap Up
ACON
Aclarion
1.5878 of 5 stars
$7.15
+0.8%
$11,758.50
+164,354.5%
-99.6%$4.13M$50K0.007
ATIP
ATI Physical Therapy
N/A$0.68
flat
N/A-88.6%$2.98M$741.86M-0.045,600
OTRK
Ontrak
2.1817 of 5 stars
$0.37
-12.1%
$3.00
+700.4%
-98.2%$1.80M$10.85M-0.02250Gap Down
NIVF
NewGenIvf Group
N/A$1.92
+1.1%
N/A-99.8%$1.64M$5.43M0.00N/APositive News
BACK
IMAC
N/A$0.07
-0.1%
N/A-95.5%$147K$72.05K0.00180Gap Up
BTTX
Better Therapeutics
N/AN/AN/A+0.0%$5KN/A0.0040

Related Companies and Tools


This page (NASDAQ:DHAC) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners